DURATA THERAPEUTICS INC COM STK (DE)
DRTX
DRTX was delisted on the 17th of November, 2014.
74 hedge funds and large institutions have $229M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 10 reducing their positions, and 11 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 10
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
33% more capital invested
Capital invested by funds: $172M → $229M (+$56.8M)
25% more funds holding
Funds holding: 59 → 74 (+15)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
57% less call options, than puts
Call options by funds: $2.41M | Put options by funds: $5.55M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$14.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.9M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.43M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$1.52M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$14.9M |
| 2 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$12.6M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$1.42M |
| 4 |
Millennium Management
New York
|
-$852K |
| 5 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$459K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
76
Sophrosyne Capital
New York
| – | -$1.42M | -105,500 | Closed |
|
|
SIM
77
SSI Investment Management
Los Angeles,
California
| – | -$459K | -33,985 | Closed |
|
|
TC
78
TFS Capital
West Chester,
Pennsylvania
| – | -$350K | -25,976 | Closed |
|
79
ProShare Advisors
Bethesda,
Maryland
| – | -$187K | -13,240 | Closed |
|
|
SKK
80
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$165K | -12,270 | Closed |
|
|
JMPWA
81
JP Morgan Private Wealth Advisors
San Francisco,
California
| – | -$135K | -10,000 | Closed |
|
|
SO
82
STRS Ohio
Columbus,
Ohio
| – | -$83K | -6,200 | Closed |
|
|
PVH
83
Psagot Value Holdings
Tel Aviv,
Israel
| – | -$63K | -4,675 | Closed |
|
|
TRCT
84
Tower Research Capital (TRC)
New York
| – | -$46K | -3,432 | Closed |
|
|
TDC
85
Thompson Davis & Co
Richmond,
Virginia
| – | -$3K | -250 | Closed |
|
DRTX Hedge Fund Activity: Q2 2014 in Review
74 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q2 2014, worth a combined $229M — up 33% from $172M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new DRTX positions and 11 closed out — a net gain of 15 holders — while 30 added to existing stakes and 10 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $14.9M. The largest seller was Aisling Capital, cutting an estimated $14.9M.
- 74 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q2 2014, up from 59 in Q1 2014.
- Funds reported $229M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q2 2014, up 33% quarter-over-quarter.
- 26 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q2 2014 and 11 closed out, a net change of +15 holders.
- The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q2 2014 was OppenheimerFunds, an estimated $14.9M added.
- The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q2 2014 was Aisling Capital, an estimated $14.9M sold.
Based on aggregated 13F filings for Q2 2014.